ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

USC Opts for Its own IL-2 Protocol, Shuns NCI Trial

May 8, 1987

ONS Scientific Program Grows

June 20, 1980

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

AACR to honor eight scientists with lecture awards.

February 13, 2004